Global Cord Blood Corporation
Simbol: CO
NYSE
2.9876
USDTržna cena danes
5.2326
Razmerje P/E
-0.0019
Razmerje PEG
400.08M
Kapaciteta MRK
- 0.00%
Donos DIV
Global Cord Blood Corporation (CO) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 6661 | 6075.8 | 5473.4 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.net-receivables | 0 | 161.3 | 130.3 | 104.3 | ||||||||||||||||
balance-sheet.row.inventory | 0 | 45.9 | 44.3 | 43.8 | ||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 11.9 | 47.8 | 44.8 | ||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 6935 | 6298.1 | 5666.2 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 476.7 | 503.7 | 527.2 | ||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 83.6 | 88.2 | 92.8 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 83.6 | 88.2 | 92.8 | ||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 282.3 | 307 | 290.4 | ||||||||||||||||
balance-sheet.row.tax-assets | 0 | 60.8 | 55.8 | 50.7 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 696.2 | 653.4 | 592.5 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1599.5 | 1608.2 | 1553.7 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 0 | 8534.5 | 7906.3 | 7219.9 | ||||||||||||||||
balance-sheet.row.account-payables | 0 | 8.3 | 9.5 | 20 | ||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 0.1 | 1.6 | 1.7 | ||||||||||||||||
balance-sheet.row.tax-payables | 0 | 31.2 | 29.5 | 32.3 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0.1 | 1.8 | ||||||||||||||||
Deferred Revenue Non Current | 0 | 2473.5 | 2392.9 | 2289.8 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 179.8 | 166 | 146.3 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 3003 | 2891.4 | 2760.6 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0.1 | 1.8 | 3.5 | ||||||||||||||||
balance-sheet.row.total-liab | 0 | 3649.6 | 3517.9 | 3331.4 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | ||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 2887.3 | 2386.2 | 1877.9 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -106.8 | -103.2 | -94.7 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2098.8 | 2098.8 | 2098.8 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 4879.3 | 4381.9 | 3882.1 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 8534.5 | 7906.3 | 7219.9 | ||||||||||||||||
balance-sheet.row.minority-interest | 0 | 5.7 | 6.6 | 6.4 | ||||||||||||||||
balance-sheet.row.total-equity | 0 | 4885 | 4388.5 | 3888.5 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||
Total Investments | 0 | 282.3 | 307 | 290.4 | ||||||||||||||||
balance-sheet.row.total-debt | 0 | 0.1 | 1.8 | 3.5 | ||||||||||||||||
balance-sheet.row.net-debt | 0 | -6660.8 | -6074 | -5469.9 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 509.5 | 516.2 | 477.7 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 47.9 | 49.1 | 49.4 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 3.2 | -7.2 | -7.2 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 11.7 | 37.6 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -3.8 | 58.3 | 64.1 | ||||||||||||||||
cash-flows.row.account-receivables | 0 | -102.9 | -120.4 | -86.9 | ||||||||||||||||
cash-flows.row.inventory | 0 | -5.3 | -6.8 | -24.1 | ||||||||||||||||
cash-flows.row.account-payables | 0 | -1.1 | -10.5 | -13.6 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | 105.7 | 196.1 | 188.6 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 56.7 | 2.6 | 2.3 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -19.8 | -20.9 | -24.2 | ||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -340 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 210 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0.2 | 0.8 | 8.2 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -19.6 | -20.1 | -146.1 | ||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -7.7 | -6.1 | -4 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -7.7 | -6.1 | -4 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -1.1 | -2.1 | 1.6 | ||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 585.2 | 602.4 | 475.5 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 6661 | 6075.8 | 5473.4 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 6075.8 | 5473.4 | 4997.9 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 613.6 | 630.7 | 624 | ||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -19.8 | -20.9 | -24.2 | ||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 593.8 | 609.8 | 599.8 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1243.3 | 1159.6 | 1221.5 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 183.3 | 178.9 | 189.1 | ||||||||||||||||
income-statement-row.row.gross-profit | 0 | 1059.9 | 980.7 | 1032.3 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | 0 | 6.3 | 8.2 | 7.4 | ||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 451.1 | 435.8 | 473.3 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 634.4 | 614.8 | 662.4 | ||||||||||||||||
income-statement-row.row.interest-income | 0 | 32.6 | 30.9 | 25.4 | ||||||||||||||||
income-statement-row.row.interest-expense | 0 | -38.6 | 0 | 0 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 19 | 65.9 | 19.8 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 6.3 | 8.2 | 7.4 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 19 | 65.9 | 19.8 | ||||||||||||||||
income-statement-row.row.interest-expense | 0 | -38.6 | 0 | 0 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 19.9 | -26.8 | 13 | ||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | 0 | 608.9 | 544.9 | 559 | ||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 627.8 | 610.8 | 578.8 | ||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 118.4 | 94.5 | 101.1 | ||||||||||||||||
income-statement-row.row.net-income | 0 | 501.1 | 508.2 | 470.7 |
Pogosto zastavljeno vprašanje
Kaj je Global Cord Blood Corporation (CO) skupna sredstva?
Global Cord Blood Corporation (CO) skupna sredstva so 8534525000.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so N/A.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.853.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je 4.885.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je 0.403.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so 0.490.
Kaj je Global Cord Blood Corporation (CO) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je 501065000.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 147000.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 451083000.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 0.000.